< Back

Pharma C Investments Plc

AQSE Growth Market -
(Suspended)
The Company was incorporated on 28 August 2018 as an investment vehicle (being a SPAC under the AQSE Growth Market Access Rulebook) to identify investment opportunities and make acquisitions in companies; it is specifically seeking to take advantage of the dynamic regulatory environment surrounding legal Medicinal Cannabis. The Company will focus on identifying investment opportunities in companies that provide ancillary products and services which serve the Medicinal Cannabis sector, not just in Europe, but in markets globally (with a particular focus on the United Kingdom, Europe and Israel) that are internationally recognised as having well- developed and reputable laws and regulations for the research and production of Medicinal Cannabis and that comply with the United Nations’ Convention on Narcotic Drugs. The Company expects to provide investee companies with strategic insights, assist with helping them realise their growth strategy and provide operational support as they develop.

pharmacinvestments.com
Symbol Ccy Code Bid Ask Share Price (Mid) Previous Close Volume Last Traded
PCIL GBX 0.13 0.15 0.14 0.14 1000000 16.08.22

MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.

Key Information

  
Market Cap: £377,800
ISIN:GB00BJDPYD55
Par:0
Inst Type:Ordinaries
Symbol:PCIL
MIFID Status:MTF
Tradable securities in issue:269,857,144
Sector:Financial Services
% daily price change:0.00%

Latest Trades

Date & Time Volume Price
16.08.22  |  09:46:0510000000.108
10.08.22  |  11:43:207526880.1302
26.07.22  |  14:57:1225000000.15
26.07.22  |  14:55:4025000000.15
26.07.22  |  10:17:281000000.16
25.07.22  |  11:12:1843343400.1
25.07.22  |  11:12:0130000000.13
05.07.22  |  12:55:0011114470.1
13.05.22  |  13:42:2620000000.175
13.05.22  |  13:38:561000000.23
View all trades >

Latest Announcements

Date & Time Title
24.11.22  |  16:57:00Pharma C Investments - Notice of AGM
18.11.22  |  17:26:00Pharma C Investments - Half-year Report and Notice of AGM
30.06.22  |  14:23:00Pharma C Investments - Annual Financial Report
30.06.22  |  10:29:00Pharma C Investments - Issue of Equity
28.03.22  |  15:14:00Pharma C Investments - Investment in Summerway Capital
30.12.21  |  12:19:00Pharma C Investments - Board Changes
08.11.21  |  07:00:00Pharma C Investments - Pharma C Invests in Product Earth Expo
28.09.21  |  07:00:00Pharma C Investments - Interim Results
25.06.21  |  07:00:00Pharma C Investments - Board Change and Appointment of Corporate Advisor
26.05.21  |  07:00:00Pharma C Investments - Admission to AQSE Growth Market and Fundraising
View all announcements >

Address

Business Address

Pharma C Investments Plc, 19 Compton Avenue, London, N1 2XD, United Kingdom.

Email: gavin@pharmacinvestments.com

Phone: 07897 834092

Registered Address

85 First Floor, Great Portland Street, London, W1W 7LT, United Kingdom.

Contacts

Corporate Adviser

Novum Securities, 2nd Floor Lansdowne House, 57 Berkeley Square, London, United Kingdom.

Email: corporatefinance@novumsecurities.com

Phone: 020 7399 9400

Registrar

Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom.

Email: info@nevilleregistrars.co.uk

Phone: +44 (0) 121 585 1131

Research


There is no research available.